Stay Connected with ERT:
- Regulatory Trends in Reviewing Risk/Benefit Assessments: U.S. FDA Perspective
- Drug-induced Hypertension – Potential New FDA Guidance?
- Why Use Ambulatory Blood Pressure Monitoring (ABPM) in Clinical Research?
- Improving Your Drug’s Value Proposition throughout the Product Lifecycle: How Optimized Clinical Outcomes Assessment (COA) Strategies Can Drive Commercialization Success
- Metrics Champion Consortium – Cardiopulmonary Performance Metrics Initiative
Monthly Archives: March 2011
Hello and welcome, we are bringing this to you live from Arizona! We are here attending the Partnerships in Clinical Trials conference, and so far everything is going great! This post, will discuss the strategic alliances and partner relationships that have … Continue reading
Editor’s Note: Less than one month after returning from our trip, the north coast of Japan was hit by a horrible tsunami after an 8.9 magnitude earthquake that occurred 80 miles offshore. Tsunami waves caused massive destruction and massive loss … Continue reading